The Federal Trade Commission has given the green light to Amgen's purchase of Horizon Therapeutics.

Share:
More In Business
Inflation Worries Aren’t Quite Over Yet
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
Load More